Drug · DIN 02506564
TRURAPI
CARTRIDGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 30, 2021; first marketed March 30, 2021.
- Drug Identification Number (DIN)
- 02506564
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin aspart A10AB05
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN ASPART | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 15, 2020: NOC 24472New Drug Submission (NDS)
Other DINs named TRURAPI
- DIN 02506572 · Marketed
- DIN 02529254 · Marketed